Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
bioAffinity Technologies
NasdaqCM:BIAF Community
0
Narratives
written by author
0
Comments
on narratives written by author
0
Fair Values set
on narratives written by author
Create a narrative
bioAffinity Technologies
Popular
Undervalued
Overvalued
There are no community narratives available.
Your Valuation for
BIAF
bioAffinity Technologies
Your Fair Value
US$
Current Price
US$0.28
92.7% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-12m
21m
2015
2018
2021
2024
2025
2027
2030
Revenue US$21.5m
Earnings US$4.3m
Advanced
Set as Fair Value
